Torrey Growth & Income Advisors’s Merck MRK Stock Holding History

Torrey Growth & Income Advisors’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-2,668	Closed	-$224K	–	129
2025 Q3	$224K	Buy	+2,668	New	+$220K	0.07%	112

Other funds holding MRK

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Torrey Growth & Income Advisors's MRK Position: Q4 2025 in Review

Torrey Growth & Income Advisors sold out of Merck (MRK) in Q4 2025, closing a stake of 2,668 shares — an estimated $224K sold.

Torrey Growth & Income Advisors first reported a position in MRK in Q3 2025 and held it in 1 quarter. The position peaked at $224K in Q3 2025. 3,660 funds tracked by Wall St. Rank hold MRK as of Q4 2025.

Torrey Growth & Income Advisors reported no remaining Merck position as of Q4 2025 after selling out during the quarter.
Torrey Growth & Income Advisors sold 2,668 Merck shares in Q4 2025, an estimated $224K.
Torrey Growth & Income Advisors first reported a position in Merck in Q3 2025 and held it in 1 quarter.
Torrey Growth & Income Advisors's Merck position peaked at $224K in Q3 2025.
3,660 funds tracked by Wall St. Rank held Merck as of Q4 2025.

Based on Torrey Growth & Income Advisors's 13F filing for Q4 2025, filed 17 Feb 2026.